GALECTIN THERAPEUTICS INC (GALT) Nonoperating Income (Expense) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Galectin Therapeutics Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2024.
  • Galectin Therapeutics Inc Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$1.84 M, a 55.4% decline year-over-year.
  • Galectin Therapeutics Inc Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$3.65 M, a 126% decline year-over-year.
  • Galectin Therapeutics Inc annual Nonoperating Income (Expense) for 2023 was -$2.99 M, a 606% decline from 2022.
  • Galectin Therapeutics Inc annual Nonoperating Income (Expense) for 2022 was -$424 K, a 21.8% decline from 2021.
  • Galectin Therapeutics Inc annual Nonoperating Income (Expense) for 2021 was -$348 K, a 1557% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$3.65 M -$1.84 M -$656 K -55.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$2.99 M -$436 K -$435 K -43500% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$2.56 M -$1.26 M -$787 K -166% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$1.77 M -$111 K -$160 K -327% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$1.61 M -$1.19 M -$1.19 M -39600% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$424 K -$1 K -$206 K -100% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$218 K -$475 K -$199 K -72.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$19 K $49 K +$305 K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$324 K $3 K +$24 K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$348 K $205 K +$225 K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$573 K -$276 K -$259 K -1524% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$314 K -$256 K -$244 K -2033% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$70 K -$21 K -$49 K -175% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$21 K -$20 K -$71 K -139% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $50 K -$17 K -$96 K -122% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $146 K -$12 K -$34 K -155% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $180 K $28 K +$36 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $144 K $51 K +$116 K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $28 K $79 K +$151 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$123 K $22 K +$103 K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$226 K -$8 K +$72 K +90% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$298 K -$65 K -$56 K -622% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$242 K -$72 K -$78 K -1300% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$164 K -$81 K -$87 K -1450% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$77 K -$80 K -$89 K -989% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $12 K -$9 K -$17 K -213% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 $29 K $6 K -$5 K -45.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $34 K $6 K -$6 K -50% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $40 K $9 K -$5 K -35.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $45 K $8 K -$4 K -33.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 $49 K $11 K -$1 K -8.33% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $50 K $12 K -$2 K -14.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $52 K $14 K $0 0% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $52 K $12 K +$9 K +300% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-28
Q3 2015 $43 K $12 K +$53 K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$10 K $14 K +$68 K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$78 K $14 K +$280 K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$358 K $3 K -$2 K -40% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$356 K -$41 K -$44 K -1467% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$312 K -$54 K -$57 K -1900% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$255 K -$266 K -$271 K -5420% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $16 K $5 K -$1 K -16.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $17 K $3 K -$204 K -98.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $221 K $3 K -$5 K -62.5% Mar 30, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $226 K $5 K +$2 K +66.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 $224 K $6 K +$2 K +50% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-18
Q3 2012 $222 K $207 K +$202 K +4040% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $20 K $8 K +$144 K Mar 29, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$124 K $3 K +$382 K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$506 K $4 K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-29
Q3 2011 $5 K -$98 K -95.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$136 K +$168 K +55.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-10
Q1 2011 -$379 K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 $103 K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$304 K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.